Oscar Health Reports $5,139,298 Quarterly Revenue
Oscar Health reported quarterly results highlighted by oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook, according to its earnings release filed with an 8-K Thursday.
Total revenue $5,139,298 $2,985,984 $14,666,712 $8,896,192. Net income (loss) attributable to Oscar Health, Inc. $167,281 $(137,450) $1,208,085 $(90,540). (2) Represents total membership for our former co-branded partnership with Cigna. We did not renew the Cigna+Oscar Small Group arrangement after its initial term ended on December 31, 2024. 2026 Financial Guidance Summary.
Results detail
Further figures in the release included Prior Full Year 2026 Outlook Updated Full Year 2026 Outlook; (4) Earnings from operations is the Company's total revenue less total operating expenses. We believe earnings from operations is an important primary metric for assessing operating performance; Adjusted EBITDA was $206.9 million for the third quarter of 2026 compared to an adjusted EBITDA loss of $101.5 million for the third quarter of 2025.
The filing is an Item 2.02 results announcement furnished with Exhibit 99.1. Comparisons use the year-earlier period as presented by Oscar Health unless the release specifies another baseline. Where both GAAP and non-GAAP metrics appear, both are summarized when the extract includes them.
Segment mix, cash flow and any outlook language in the release are the usual secondary reads after the headline revenue and earnings figures. One-time items—restructuring, impairments, gains on sales or legal settlements—can move GAAP profit without changing the run-rate story, so reconciliations remain essential.
Why it matters
For retail investors, the Oscar Health print is a check on whether growth, margins and cash generation are moving together. The figures above come from the company’s Exhibit 99.1 earnings materials; how they stack up against the prior-year run rate and any guide published with the release will shape the near-term debate.
By the numbers
- Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook
- Total revenue $5,139,298 $2,985,984 $14,666,712 $8,896,192
- Net income (loss) attributable to Oscar Health, Inc. $167,281 $(137,450) $1,208,085 $(90,540)
- (2) Represents total membership for our former co-branded partnership with Cigna. We did not renew the Cigna+Oscar Small Group arrangement after its initial term ended on December 31, 2024.
- 2026 Financial Guidance Summary
- Prior Full Year 2026 Outlook Updated Full Year 2026 Outlook
Sources
- Oscar Health, Inc. Form 8-K with quarterly financial results, filed 2026-11-05 (accession 0001568651-26-000082)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.